Early access to medicinal products: potential and limits, Orphanet Journal of Rare Diseases, vol.9, issue.Suppl 1 ,
DOI : 10.1038/clpt.2011.345
URL : https://doi.org/10.1186/1750-1172-9-s1-o24
Rendre possible un accès plus précoce au médicament, 2005. ,
5121-8 du code de la santé publique 7. http://www.leem.org/article/comment-se-decide-une-autorisation-de-mise-sur-marche- 0, 2017. ,
Master AREIPS Lille Réflexions sur le concept «Adaptive Licensing / Pathway» -«extrait de H-G Eichler ?EMA» 41. Final report on the adaptive pathways pilot http, Report, issue.08, 2016. ,
fractionnées " : les projets imprudents de l'agence européenne du médicament » - Prescrire http://www.prescrire.org, 2017. ,
Era Of Faster FDA Drug Approval Has Also Seen Increased Black-Box Warnings And Market Withdrawals, Health Affairs, vol.33, issue.8, pp.1453-1459, 2014. ,
DOI : 10.1377/hlthaff.2014.0122